Ramirez Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ramirez Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123K	Hold	775	–	–	0.01%	217
2026 Q1	$99K	Sell	775 -500	-39%	-$62.4K	0.01%	217
2025 Q4	$155K	Hold	1,275	–	–	0.02%	220
2025 Q3	$128K	Hold	1,275	–	–	0.02%	233
2025 Q2	$106K	Sell	1,275 -200	-14%	-$16K	0.02%	241
2025 Q1	$120K	Buy	1,475 +100	+7%	+$8.94K	0.02%	237
2024 Q4	$124K	Hold	1,375	–	–	0.03%	248
2024 Q3	$136K	Hold	1,375	–	–	0.03%	237
2024 Q2	$127K	Hold	1,375	–	–	0.03%	246
2024 Q1	$130K	Hold	1,375	–	–	0.03%	242
2023 Q4	$123K	Hold	1,375	–	–	0.02%	251
2023 Q3	$100K	Buy	+1,375	New	+$110K	0.02%	262

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Ramirez Asset Management's XBI Position: Q2 2026 in Review

Ramirez Asset Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 775 shares worth $123K. The position accounts for 0.01% of the portfolio, ranked #217.

Ramirez Asset Management first reported a position in XBI in Q3 2023 and has held it in 12 quarters since. The position peaked at $155K in Q4 2025. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Ramirez Asset Management held 775 shares of State Street SPDR S&P Biotech ETF worth $123K as of Q2 2026.
Ramirez Asset Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Ramirez Asset Management's portfolio in Q2 2026, its #217 holding.
Ramirez Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and has held it in 12 quarters since.
Ramirez Asset Management's State Street SPDR S&P Biotech ETF position peaked at $155K in Q4 2025.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Ramirez Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.